Nav: Home

Researchers investigate potential treatments for COVID-19

March 26, 2020

Washington, DC - March 23, 2020 - The number of potential therapeutic options for treatment of COVID-19 is growing. Approaches include blocking SARS-CoV-2 from entering cells, disrupting the virus' replication, antivirals, vaccines, and suppressing overactive immune response.

The research was published in a minireview, and in a short article in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology. The authors of the former suggest that therapeutic drugs directly targeting SARS-CoV-2 will be most effective.

SARS-CoV-2 is easily transmissible because spike proteins on the virus' surface bind exceptionally efficiently to "angiotensin-converting enzyme 2" (ACE2) on the surfaces of human cells. A pilot clinical trial is underway in patients with severe COVID-19, investigating use of recombinant human ACE2 to act as "decoys" that would attach to spike proteins, disabling SARS-CoV-2's mechanism for entry into human cells.

The most promising antiviral for fighting SARS-CoV-2 is remdesivir. It gets incorporated into nascent viral RNA, where it prevents RNA synthesis, and in turn, further viral replication. Remdesivir inhibited SARS-CoV-2 replication in laboratory studies, and the clinical condition of the first confirmed case of COVID-19 in the U.S. improved following intravenous remdesivir administration. But more data is needed.

Tilarone, a broad spectrum antiviral, may also be active against SARS-CoV-2. This 50-year-old synthetic small molecule is used in some Russian Federation countries and neighboring countries against multiple viruses, including acute respiratory viral infection, influenza and hepatitis. Recent observations suggest tilarone is active against chikungunya virus and MERS-CoV.

While tilarone is approved in Russian Federation countries, it has not been tested for safety and efficacy in studies that meet U.S. Food and Drug Administration standards.

Another approach being researched is the transfusion of blood from recovered patients--which contain antibodies against the virus--into current patients. Due to lack of high quality randomized clinical trials and knowledge of the precise mechanism of action, it is not clear how effective this therapy is. It is used mainly in patients in critical condition. Several clinical trials investigating its effectiveness and safety against COVID-19 are now in progress.

More than fifteen vaccine candidates are being developed around the world, which take different approaches to vaccine design. Experts say vaccine development will take approximately 12-18 months.
-end-
Read the article on asm.org about antimicrobials for COVID-19, strategies for treating a pandemic.

The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of 30,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.

ASM advances the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.

American Society for Microbiology

Related Microbiology Articles:

79 Fellows elected to the American Academy of Microbiology
In January of 2015, the American Academy of Microbiology elected 79 new Fellows.
New discovery in the microbiology of serious human disease
Previously undiscovered secrets of how human cells interact with a bacterium which causes a serious human disease have been revealed in new research by microbiologists at The University of Nottingham.
4 cells turn seabed microbiology upside down
With DNA from just four cells, researchers reveal how some of the world's most abundant organisms play a key role in carbon cycling in the seabed.
87 scientists elected to the American Academy of Microbiology
Eighty-seven microbiologists have been elected to Fellowship in the American Academy of Microbiology.
Tips from the journals of the American Society for Microbiology
This release includes information about these articles: Specific Bacterial Species May Initiate, Maintain Crohn's; Bacteria Involved in Sewer Pipe Corrosion Identified; Antibodies to Immune Cells Protect Eyes In Pseudomonas Infection; Dangerous Form of MRSA, Endemic In Many US Hospitals, Increasing in UK.
Tips from the journals of the American Society for Microbiology
Upcoming articles from the journals of the American Society for Microbiology include:
Microbiology brought to life in Nottingham
Antimicrobial insect brains, mouth bacteria behaving badly and the hundreds of microbial communities that lurk in household dust are just some of the highlights at the Society for General Microbiology's autumn meeting in Nottingham next week.
Tips from the journals of the American Society for Microbiology
The following are tips from the journals of the American Society for Microbiology:
Tips from the journals of the American Society for Microbiology
The following are tips from the Journals of the American Society for Microbiology:
New text focuses on microbiology of historic artifacts
Historic and culturally important artifacts, like all materials, are vulnerable to microbial attack.
More Microbiology News and Microbiology Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Uncharted
There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#555 Coronavirus
It's everywhere, and it felt disingenuous for us here at Science for the People to avoid it, so here is our episode on Coronavirus. It's ok to give this one a skip if this isn't what you want to listen to right now. Check out the links below for other great podcasts mentioned in the intro. Host Rachelle Saunders gets us up to date on what the Coronavirus is, how it spreads, and what we know and don't know with Dr Jason Kindrachuk, Assistant Professor in the Department of Medical Microbiology and infectious diseases at the University of Manitoba. And...
Now Playing: Radiolab

Dispatch 1: Numbers
In a recent Radiolab group huddle, with coronavirus unraveling around us, the team found themselves grappling with all the numbers connected to COVID-19. Our new found 6 foot bubbles of personal space. Three percent mortality rate (or 1, or 2, or 4). 7,000 cases (now, much much more). So in the wake of that meeting, we reflect on the onslaught of numbers - what they reveal, and what they hide.  Support Radiolab today at Radiolab.org/donate.